Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Aurion Biotech
Aurion Biotech Achieves All Primary, Secondary, and Exploratory Endpoints in AURN001 Phase 1/2 CLARA Trial at 12 Months
October 18, 2025
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Expands Leadership Team, Promoting Andrew Torres, Ph.D., to Chief Manufacturing Officer and Sterling Chung to Chief Regulatory & Quality Officer
September 30, 2025
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Appoints Edward J. Holland, M.D., as Chief Medical Officer and Eris P. Jordan, O.D., as Chief Development Officer
April 23, 2025
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Launches Vyznova® (neltependocel) in Japan for the Treatment of Bullous Keratopathy of the Cornea
September 24, 2024
From
Aurion Biotech
Via
Business Wire
Aurion Biotech to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) and Ophthalmology European Futures Forum
September 03, 2024
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001
June 19, 2024
From
Aurion Biotech
Via
Business Wire
Aurion Biotech CEO Greg Kunst Named Ernst & Young 2024 Entrepreneur of the Year Mountain West Region
June 17, 2024
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Announces Completion of Enrollment in Phase 1 / 2 Clinical Trial
April 30, 2024
From
Aurion Biotech
Via
Business Wire
Aurion Biotech to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
April 02, 2024
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial
March 28, 2024
From
Aurion Biotech
Via
Business Wire
Greg Kunst, CEO of Aurion Biotech, Receives Healthcare Leadership Award from Puget Sound Business Journal
December 07, 2023
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Named “Regenerative Therapeutics Company Of The Year” By BioTech Breakthrough
November 08, 2023
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Announces First Subject Dosed in U.S. Phase 1 / 2 Clinical Trial
October 24, 2023
From
Aurion Biotech
Via
Business Wire
Aurion Biotech to Present Clinical Trial Results at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
May 02, 2023
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application
March 23, 2023
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Appoints Jonathan Sparks, JD, PhD as Chief Legal Officer
December 07, 2022
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Expands Its Leadership Team
November 30, 2022
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Wins Prestigious Prix Galien Startup Award
October 27, 2022
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Nominated for Prix Galien Startup Award
August 18, 2022
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer
June 09, 2022
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Raises $120 Million from Deerfield Management, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures
April 12, 2022
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Announces Medical Advisory Board
October 19, 2021
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Announces Strategic Investments in Manufacturing
September 14, 2021
From
Aurion Biotech
Via
Business Wire
Daniela Drago Joins Aurion Biotech as Chief Regulatory Officer
August 10, 2021
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Announces IOTA Cell Therapy Trial
July 25, 2021
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Appoints Professor Shigeru Kinoshita, MD, PhD, to Its Medical Advisory Board
July 13, 2021
From
Aurion Biotech
Via
Business Wire
Aurion Biotech Names Edward Holland, MD, Chief Medical Advisor
June 29, 2021
From
Aurion Biotech
Via
Business Wire
Arnaud Lacoste Is Named Chief Scientific Officer of Aurion Biotech
June 15, 2021
From
Aurion Biotech
Via
Business Wire
Greg Kunst Appointed CEO of Aurion Biotech
June 08, 2021
From
Aurion Biotech
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.